CytomX Therapeutics (CTMX) EPS (Diluted) Growth (1y) (2020 - 2026)
CytomX Therapeutics (CTMX) EPS (Diluted) Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 36.94% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17,091.12% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 61.58% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -7.16% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 96.09% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CytomX Therapeutics | 590.32 Mn | 243.61 Mn | - | -138.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -138.13% |
| Dec 31, 2025 | -173.80% |
| Sep 30, 2025 | -228.10% |
| Jun 30, 2025 | 98.45% |
| Mar 31, 2025 | 61.73% |
| Dec 31, 2024 | 1,864.15% |
| Sep 30, 2024 | 82.23% |
| Jun 30, 2024 | -371.19% |
| Mar 31, 2024 | 433.95% |
| Dec 31, 2023 | 108.50% |
| Sep 30, 2023 | 108.38% |
| Jun 30, 2023 | 96.37% |
| Mar 31, 2023 | 89.78% |
| Dec 31, 2022 | 75.41% |
| Sep 30, 2022 | 7.19% |
| Jun 30, 2022 | -9.50% |
| Mar 31, 2022 | -27.81% |
| Dec 31, 2021 | -4.35% |
| Sep 30, 2021 | 12.70% |
| Jun 30, 2021 | 25.45% |